OTC · Biotechnology

American CryoStem Corporation (CRYO) Stock

$0.00 OTC: CRYO Healthcare

American CryoStem Corporation (ACSC) specializes in the development, commercialization, and licensing of technologies derived from adipose (fat) tissue, primarily for applications within regenerative and personalized medicine. Among its key offerings is the CELLECT system, designed to streamline tissue sample collection, transportation, and storage for medical practitioners.

Valuation

MetricValue
Price$0.00
Market Cap$4428
P/E Ratio0.00
P/B Ratio0.00
P/S Ratio0.22
EPS (TTM)$-0.05
52-Week High$4.00
52-Week Low—
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE150.00%
ROA-300.00%
ROCE383.76%
Gross Margin34.08%
Operating Margin—
Net Margin—
Debt/Equity-0.50
Current Ratio0.12

Annual Financials (USD)

Metric20172018201920202021
Revenue$2.0M$1.0M$0$1.0M$0
Operating Profit$-1.0M$-1.0M$-1.0M$-1.0M$-2.0M
Net Profit$-1.0M$-1.0M$-1.0M$-1.0M$-3.0M
EPS$-0.03$-0.03$-0.02$-0.02$-0.05
Op Margin-54.7%-115.3%-295.7%-105.6%-10710.6%

Balance Sheet (USD)

Metric20172018201920202021
Total Assets$1.0M$1.0M$1.0M$1.0M$1.0M
Total Liabilities$2.0M$2.0M$3.0M$2.0M$3.0M
Cash$0$0$0$0$0
Borrowings$1.0M$1.0M$1.0M$1.0M$1.0M

Latest News

Cryoport (CYRX) Stock Fair Value Rises After Analysts Lift Targets On Growth Trends Simply Wall St. · Jul 27, 2026 Cryoport to Report Second Quarter 2026 Financial Results on August 6, 2026 PR Newswire · Jul 23, 2026 CryoPort to Provide IntegriCell Cryopreservation Services for Verismo's Development Programs MT Newswires · Jun 25, 2026 Cryoport's IntegriCell® Cryopreservation Services Selected by Verismo Therapeutics to Support Clinical KIR-CAR T Cell Therapy Programs PR Newswire · Jun 25, 2026 Cryoport (CYRX) Stock Fair Value Rises After Analysts Revisit Bioservices Outlook Simply Wall St. · Jun 13, 2026

Cash Flow (USD)

Metric20172018201920202021
Operating Cash Flow$0$0$0$-1.0M$0
Investing Cash Flow$0$-1.0M$0$0$0
Financing Cash Flow$0$0$1.0M$1.0M$0
Net Cash Flow$0$0$0$0$0
Free Cash Flow$0$0$-1.0M$-1.0M$0

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.53
FCF Yield-8926.49%
Quick Ratio0.11
Interest Coverage-21.24
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ABMCAmerican Bio Medica Corporation $0.00 — 0.00 $4810 0.00%
ACCAAcacia Diversified Holdings, Inc. $0.00 — 0.00 $5428 0.00%
AHPIQAllied Healthcare Products, Inc. $0.00 — — $4010 0.00%
CRXMGene Biotherapeutics, Inc. $0.00 — 0.00 $6493 0.00%
DMTKQDermTech, Inc. $0.00 — 0.00 $3496 0.00%

About American CryoStem Corporation

American CryoStem Corporation (ACSC) specializes in the development, commercialization, and licensing of technologies derived from adipose (fat) tissue, primarily for applications within regenerative and personalized medicine. Among its key offerings is the CELLECT system, designed to streamline tissue sample collection, transportation, and storage for medical practitioners. The company also provides the ATGRAFT service, a comprehensive solution for harvesting, processing, and preserving adipose tissue, enabling physicians to offer patients versatile options for tissue products and cellular banking. Complementing these are ATCELL, a line of proprietary adipose-derived stem cells, and ACSelerat cell culture media, specifically formulated to promote the growth of human stromal cells. Furthermore, American CryoStem extends its expertise through contract manufacturing services for specific formulations, including Autokine-CM, an anti-aging topical product, and a unique autologous skin care range. Founded in 1987, American CryoStem Corporation is headquartered in Eatontown, New Jersey.

American CryoStem Corporation (CRYO) stock trades at $0.00 with a market capitalization of $4428. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.00, price-to-sales of 0.22.

On profitability, American CryoStem Corporation generates a return on equity (ROE) of 150.00% — well above the market average, a sign of a high-quality business, return on capital employed of 383.76%.

Official website: www.americancryostem.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides